Pfizer prices Covid-19 treatment Paxlovid at $1,390 - WSJPFE -0.70% Add to/Remove from WatchlistPfizer (NYSE: ) plans to price a course of its COVID-19 drug, Paxlovid, at nearly $1,400 when commercial sales commence later this year, according to the Wall Street Journal. The list price for a five-day course of the antiviral medication will be $1,390. It's worth noting that health plans are likely to negotiate lower prices than the list price for the drug. The disclosure of the list price is expected to further intensify the debate around drug pricing and access. The primary reason for this downward revision is a decline in the usage of Paxlovid, one of the company's Covid-19 drugs.

Source: Wall Street Journal October 19, 2023 11:49 UTC